product summary
Loading...
company name :
Sino Biological
product type :
protein
product name :
Human bFGF / FGF2 Protein
catalog :
10014-HNAE
quantity :
1 mg
price :
648 USD
more info or order :
citations: 41
Reference
Zhang D, Chen J, Lin H, Zhou M, Hou J, Sun W, et al. A cocktail hydrogel promoting the functional interneurons regeneration of human neural progenitor cells for brain injury therapy. J Adv Res. 2025;: pubmed publisher
Li Z, Guo Z, Yang Z, Yang B, Hu Y, Xie X, et al. Metabolite-dependent m6A methylation driven by mechanotransduction-metabolism-epitranscriptomics axis promotes bone development and regeneration. Cell Rep. 2025;44:115611 pubmed publisher
Zhang L, Lin H, Liang J, Liu X, Zhang C, Man Q, et al. Programmed death-ligand 1 regulates ameloblastoma growth and recurrence. Int J Oral Sci. 2025;17:29 pubmed publisher
Hu X, Kang B, Wang M, Lin H, Liu Z, Zhang Z, et al. Human induced pluripotent stem cells derived neutrophils display strong anti-microbial potencies. Cell Regen. 2025;14:8 pubmed publisher
Zhu Y, Chen S, Su H, Meng Y, Zang C, Ning P, et al. CPT1A-mediated MFF succinylation promotes stemness maintenance in ovarian cancer stem cells. Commun Biol. 2025;8:250 pubmed publisher
Pan Z, Yao Q, Kong W, Ma X, Tian L, Zhao Y, et al. Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery. Cell Stem Cell. 2025;32:227-245.e9 pubmed publisher
Zhang Y, Peng Z, Guo M, Wang Y, Liu J, Liu Y, et al. TET3-facilitated differentiation of human umbilical cord mesenchymal stem cells into oligodendrocyte precursor cells for spinal cord injury recovery. J Transl Med. 2024;22:1118 pubmed publisher
Liu X, Chen Y, Li Y, Bai J, Zeng Z, Wang M, et al. STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer. Biol Direct. 2024;19:59 pubmed publisher
Cao L, Han R, Zhao Y, Qin X, Li Q, Xiong H, et al. A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles. Cell Rep. 2024;43:114032 pubmed publisher
Xiong G, Xie N, Nie M, Ling R, Yun B, Xie J, et al. Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma. Int J Oral Sci. 2024;16:21 pubmed publisher
Dufresne J, Gregory M, Pinel L, Cyr D. Three-Dimensional Cell Culture of Epididymal Basal Cells and Organoids: A Novel Tool for Toxicology. Curr Protoc. 2024;4:e975 pubmed publisher
Zhang E, Chen Z, Liu W, Lin L, Wu L, Guan J, et al. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling. J Transl Med. 2024;22:12 pubmed publisher
Li L, Li D, Sun D, Zhang X, Lei W, Wu M, et al. Nuclear import carrier Hikeshi cooperates with HSP70 to promote murine oligodendrocyte differentiation and CNS myelination. Dev Cell. 2023;58:2275-2291.e6 pubmed publisher
Ye J, Liu W, Yu X, Wu L, Chen Z, Yu Y, et al. TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling. Cell Death Discov. 2023;9:378 pubmed publisher
Chen X, Tong G, Chen S. Basic fibroblast growth factor protects against liver ischemia-reperfusion injury via the Nrf2/Hippo signaling pathway. Tissue Cell. 2022;79:101921 pubmed publisher
Mou J, Huang M, Wang F, Xu X, Xie H, Lu H, et al. HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis. Mol Cancer Res. 2022;20:1724-1738 pubmed publisher
Lv X, Li Q, Liu H, Gong M, Zhao Y, Hu J, et al. JUN activation modulates chromatin accessibility to drive TNFα-induced mesenchymal transition in glioblastoma. J Cell Mol Med. 2022;26:4602-4612 pubmed publisher
Chen X, Wang P, Qiu H, Zhu Y, Zhang X, Zhang Y, et al. Integrative epigenomic and transcriptomic analysis reveals the requirement of JUNB for hematopoietic fate induction. Nat Commun. 2022;13:3131 pubmed publisher
Chi F, Jin X, Chen L, He G, Han S. TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-κB pathway. Mol Cell Biochem. 2022;477:2801-2816 pubmed publisher
Cheng Z, Yu R, Li L, Mu J, Gong Y, Wu F, et al. Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axis. Cell Mol Life Sci. 2022;79:280 pubmed publisher
Bao F, Zhou L, Zhou R, Huang Q, Chen J, Zeng S, et al. Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms. Sci Adv. 2022;8:eabk2376 pubmed publisher
Zhang K, Chen S, Yang Q, Guo S, Chen Q, Liu Z, et al. The Oligodendrocyte Transcription Factor 2 OLIG2 regulates transcriptional repression during myelinogenesis in rodents. Nat Commun. 2022;13:1423 pubmed publisher
Zhang R, Yu S, Shen Q, Zhao W, Zhang J, Wu X, et al. AXIN2 Reduces the Survival of Porcine Induced Pluripotent Stem Cells (piPSCs). Int J Mol Sci. 2021;22: pubmed publisher
Chen W, Liu N, Shen S, Zhu W, Qiao J, Chang S, et al. Fetal growth restriction impairs hippocampal neurogenesis and cognition via Tet1 in offspring. Cell Rep. 2021;37:109912 pubmed publisher
Qian Z, Li H, Yang H, Yang Q, Lu Z, Wang L, et al. Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain. Sci Adv. 2021;7:eabi5811 pubmed publisher
Zhu Z, Wu X, Li Q, Zhang J, Yu S, Shen Q, et al. Histone demethylase complexes KDM3A and KDM3B cooperate with OCT4/SOX2 to define a pluripotency gene regulatory network. FASEB J. 2021;35:e21664 pubmed publisher
Wu X, Zhu Z, Xiao X, Zhou Z, Yu S, Shen Q, et al. LIN28A inhibits DUSP family phosphatases and activates MAPK signaling pathway to maintain pluripotency in porcine induced pluripotent stem cells. Zool Res. 2021;42:377-388 pubmed publisher
Zhang F, Zhu X, Wang P, He Q, Huang H, Zheng T, et al. The cytokine FAM3B/PANDER is an FGFR ligand that promotes posterior development in Xenopus. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
Shen Q, Yu S, Zhang Y, Zhou Z, Zhu Z, Pan Q, et al. Characterization of porcine extraembryonic endoderm cells. Cell Prolif. 2019;52:e12591 pubmed publisher
Liu Z, Yan M, Liang Y, Liu M, Zhang K, Shao D, et al. Nucleoporin Seh1 Interacts with Olig2/Brd7 to Promote Oligodendrocyte Differentiation and Myelination. Neuron. 2019;102:587-601.e7 pubmed publisher
Ou Z, Ma Y, Sun Y, Zheng G, Wang S, Xing R, et al. A GPR17-cAMP-Lactate Signaling Axis in Oligodendrocytes Regulates Whole-Body Metabolism. Cell Rep. 2019;26:2984-2997.e4 pubmed publisher
Mizukami M, Onishi H, Hanagata H, Miyauchi A, Ito Y, Tokunaga H, et al. Efficient production of Trastuzumab Fab antibody fragments in Brevibacillus choshinensis expression system. Protein Expr Purif. 2018;150:109-118 pubmed publisher
Zhao Y, Ye S, Liang D, Wang P, Fu J, Ma Q, et al. In Vitro Modeling of Human Germ Cell Development Using Pluripotent Stem Cells. Stem Cell Reports. 2018;10:509-523 pubmed publisher
Shan Y, Liang Z, Xing Q, Zhang T, Wang B, Tian S, et al. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs. Nat Commun. 2017;8:672 pubmed publisher
Zhou C, Zou Q, Li H, Wang R, Liu A, Magness R, et al. Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function. J Clin Endocrinol Metab. 2017;102:3470-3479 pubmed publisher
Gao Q, Zhang J, Wang X, Liu Y, He R, Liu X, et al. The signalling receptor MCAM coordinates apical-basal polarity and planar cell polarity during morphogenesis. Nat Commun. 2017;8:15279 pubmed publisher
Chen N, Ma J, Zhao Y, Wu M, Yang H, Gong W, et al. Expression of functional recombinant human fibroblast growth factor 8b and its protective effects on MPP⁺-lesioned PC12 cells. Appl Microbiol Biotechnol. 2016;100:625-35 pubmed publisher
Quan L, Chen Y, Song J, Yan Q, Zhang Q, Lai S, et al. Establishment of a rabbit Oct4 promoter-based EGFP reporter system. PLoS ONE. 2014;9:e109728 pubmed publisher
Li Y, Lei Y, Wagner E, Xie C, Lu W, Zhu J, et al. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells. Bioconjug Chem. 2013;24:133-43 pubmed publisher
Deka Z. [Activity of the Polish Society of Social Medicine in 1916-1939]. Zdrow Publiczne. 1966;11:725-9 pubmed
Simovicov xe1 E. [Few glances at the degree of technical and medical knowledge in the field of nutrition acquired by the ancient Romans]. Bratisl Lek Listy. 1966;46:562-73 pubmed
image
image 1 :
Sino Biological 10014-HNAE image 1
product information
Catalog Number :
10014-HNAE
Product Name :
Human bFGF / FGF2 Protein
Product Type :
Protein
Host Species :
E. coli
Conjugation :
Native
Size :
1 mg
List Price :
648 USD
Gene ID :
NP_001997.5
Product Description :
A DNA sequence encoding the mature form of human bFGF (NP_001997.5) (Pro143-Ser288) was expressed with an additional Met at the N-terminus.
SpeciesSummary :
Human
ALTnames :
BFGF,FGF-2,FGFB,HBGF-2
Purity :
≥ 95 % as determined by SDS-PAGE
Buffer :
Lyophilized from sterile PBS, pH 7.4.
Packaging :
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Storage :
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
more info or order :
company information
Sino Biological
Building 9, No.18 Kechuang 10th St, BDA, Beijing, 100176
marketing@sinobiological.com
https://www.sinobiological.com
86 400-890-9989
headquarters: China
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.